Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/LVT.0000000000000598 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The impact of alcohol-associated liver disease on famous athletes who received Liver Transplants.
Liver Transpl
March 2025
UCL Institute for Liver and Digestive Health, University College London and Royal Free Hospital, London, UK.
Disparities in Health Care in Patients With Chronic Liver Disease.
J Clin Gastroenterol
March 2025
Division of Gastroenterology and Hepatology, University of California San Diego, MASLD Research Center.
Chronic liver disease (CLD) is increasing in prevalence worldwide. CLD has significant associated morbidity and mortality, including a negative impact on health-related quality of life (HRQOL), progression to cirrhosis, development of hepatocellular carcinoma (HCC), and need for liver transplantation. CLD disproportionately impacts racial, ethnic, sexual, and gender minorities.
View Article and Find Full Text PDFGlucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbidities.
Clin Nutr
February 2025
Department of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, Seoul 04401, Republic of Korea. Electronic address:
Background & Aims: This study examines the impact of glucosamine on the progression and outcomes of metabolic dysfunction-associated steatotic liver disease (MASLD), and metabolic dysfunction and alcohol-associated liver disease (MetALD) using a large scale cohort.
Methods: Present study utilized inverse probability of treatment weighting (IPTW) to adjust for confounders in this cohort study. Participants were classified based on glucosamine use, and primary and secondary outcomes included all-cause mortality, liver cirrhosis, cardiovascular disease, cerebrovascular disease, and chronic kidney disease (CKD) incidences.
Young Adults and Alcohol-Associated Liver Cancer: Incidence and Death from 2000 to 2021.
Cancers (Basel)
February 2025
Karsh Division of Gastroenterology and Hepatology, Comprehensive Transplant Center, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Background/objectives: The incidence and mortality of early-onset cancers have been rising in recent decades. While epidemiological studies have examined various types of cancer, updated global data on alcohol-attributable primary liver cancer (PLC) in young adults remains limited.
Methods: This study utilized data from the Global Burden of Disease (GBD) study spanning 2000 to 2021 to evaluate the age-standardized incidence, mortality, and corresponding rates of alcohol-attributable PLC among young adults aged 15-49 years.
Alcoholic Cardiomyopathy in Patients With Advanced Alcoholic Liver Disease: Single-Center Experience and Review of Literature.
Cardiol Rev
February 2025
From the Department of Medicine, New York Medical College, Valhalla, NY.
The impact of excessive alcohol on human health is associated with a lifetime cumulative use of alcohol and is further affected by various factors such as age, gender, nutritional status, concurrent cigarette smoking or drug use, diabetes, obesity, other cardiovascular diseases, and socio-economic status. Alcohol cardiomyopathy (ACM) is a type of acquired dilated cardiomyopathy, which is associated with long-term heavy alcohol consumption with historical rates varying from 3.8% to 47 % among patients with heart failure.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!